(Q37924701)

25 August 2017

title

Conventional apheresis therapies: a review (English)

1 reference

25 August 2017

David M Ward

1

1 reference

25 August 2017

publication date

31 August 2011

1 reference

Journal of Clinical Apheresis

25 August 2017

published in

1 reference

25 August 2017

volume

26

1 reference

25 August 2017

issue

5

1 reference

25 August 2017

page(s)

230-238

1 reference

von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome

25 August 2017

cites work

1 reference

Antiganglioside antibodies and their pathophysiological effects on Guillain-Barré syndrome and related disorders--a review

21 January 2018

1 reference

The spectrum of neuromyelitis optica

21 January 2018

1 reference

Diagnosis and treatment of neuromyelitis optica

21 January 2018

1 reference

Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis

21 January 2018

1 reference

Clinical aspects of MuSK antibody positive seronegative MG.

21 January 2018

1 reference

The immunological basis for treatment of stiff person syndrome

21 January 2018

1 reference

Removal of cardiodepressant antibodies in dilated cardiomyopathy by immunoadsorption

21 January 2018

1 reference

The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome (TTP-HUS) Registry: a community perspective of patients with clinically diagnosed TTP-HUS.

21 January 2018

1 reference

Practice parameter: Immunotherapy for Guillain-Barre syndrome: Report of the Quality Standards Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis

21 January 2018

1 reference

Evidence-based guideline update: Plasmapheresis in neurologic disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

Clinical applications of therapeutic apheresis

21 January 2018

1 reference

Introduction and overview of therapeutic apheresis

21 January 2018

1 reference

Application of specific extracorporeal removal of low density lipoprotein in familial hypercholesterolaemia

21 January 2018

1 reference

The Prosorba column for treatment of refractory rheumatoid arthritis: a randomized, double-blind, sham-controlled trial

21 January 2018

1 reference

Death by a B cell superantigen: In vivo VH-targeted apoptotic supraclonal B cell deletion by a Staphylococcal Toxin

21 January 2018

1 reference

Extracorporeal immunoadsorption: initial experience in human systemic lupus erythematosus

21 January 2018

1 reference

Removal of autoantibodies in dilated cardiomyopathy by immunoadsorption

21 January 2018

1 reference

Specific immunoadsorption therapy using a tryptophan column in patients with refractory heart failure due to dilated cardiomyopathy

21 January 2018

1 reference

Heparin-induced extracorporeal low-density lipoprotein precipitation

21 January 2018

1 reference

Increased cerebral blood flow after leukapheresis for acute myelogenous leukemia

21 January 2018

1 reference

Clinical application of therapeutic erythrocytapheresis (TEA).

21 January 2018

1 reference

Impact of leukapheresis on early death rate in adult acute myeloid leukemia presenting with hyperleukocytosis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JCA.20302

1 reference

25 August 2017

1 reference